DHR vs SER · P/E 39, rev $24.57B vs rev $56.0K
Danaher Corporation (DHR) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. SER currently screens at market cap $29.7M.
Not investment advice. Open the DHR and SER stock pages for the full models.
Not investment advice.